Anemia, Aplastic: all 348 studies
Page 3 of 4. Open to participants first (100), then studies with results posted, then the rest; newest registration first within each.
- A Trial of Hetrombopag in Healthy SubjectsCompletedNCT05088174Phase 1
- Efficacy and Safety of Hetrombopag in Non-severe Aplastic AnemiaWithdrawnNCT05018936Phase 2/3
- Extension Study of Hetrombopag in Severe Aplastic AnemiaActive, not recruitingNCT04961710Phase 3
- Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic AnemiaActive, not recruitingNCT04870346
- Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic AnemiaTerminatedNCT04854889Phase 2
- The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders.Status unknownNCT04819607
- Quantitative MRI of Bone Marrow Fat Fraction in Patients With TrepanobiopsyStatus unknownNCT04761965Not applicable
- Avatrombopag Usage in NSAAStatus unknownNCT04728789Phase 2/3
- Thrombosomes® in Bleeding Thrombocytopenic Patients StudyTerminatedNCT04631211Phase 2
- TPO-Mimetic Use in Children for Hematopoietic FailureCompletedNCT04478227Early Phase 1
- Ibrutinib for the Treatment of COVID-19 in Patients Requiring HospitalizationCompletedNCT04439006Phase 1
- Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive TherapyCompletedNCT04436380
- Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive TherapyCompletedNCT04436367
- REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive TherapyTerminatedNCT04409080Phase 1
- Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia PatientsCompletedNCT04403321Phase 2
- A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell AllograftsWithdrawnNCT04331483Not applicable
- Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCompletedNCT04128943
- Study of AMG531 (Romiplostim) in Patients With Aplastic AnemiaCompletedNCT04095936Phase 2/3
- Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment ResultsStatus unknownNCT04060485
- Ambispective Observational Study to Evaluate the Incidence and Management of Aplastic Anemia in SpainStatus unknownNCT04001686
- Study of AMG531(Romiplostim) in Patients With Aplastic AnemiaCompletedNCT03957694Phase 2/3
- A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia:Status unknownNCT03955601Phase 2
- Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantActive, not recruitingNCT03924401Phase 2
- Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic AnemiaNo longer availableNCT03906318
- Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic AnaemiaCompletedNCT03896971Phase 4
- Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell TransplantationStatus unknownNCT03836690Phase 1
- Hetrombopag or Placebo in Treatment-Naive Severe Aplastic AnemiaCompletedNCT03825744Phase 3
- Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAAStatus unknownNCT03821987Not applicable
- Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantActive, not recruitingNCT03622788Phase 1/2
- Severe Immune Cytopenia Registry Www.Sic-reg.OrgCompletedNCT03576742
- A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） PatientCompletedNCT03557099Phase 1/2
- Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AAStatus unknownNCT03413306Phase 3
- Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell TransplantationStatus unknownNCT03373526Not applicable
- Low-Dose Danazol for the Treatment of Telomere Related DiseasesCompletedNCT03312400Phase 2
- Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantActive, not recruitingNCT03301168Phase 1/2
- Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia PatientsStatus unknownNCT03295058Phase 2/3
- Haploidentical Transplantation in Severe Aplastic AnemiaStatus unknownNCT03246178Not applicable
- Eltrombopag & Cyclosporine in Children With Sever Aplastic AnemiaCompletedNCT03243656Phase 4
- Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and LevamisoleStatus unknownNCT03218657Not applicable
- Multi Center Case Control Study on Multiple Risk Factors of Aplastic AnemiaCompletedNCT03208647
- A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCTCompletedNCT03176849Phase 4
- Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot StudyWithdrawnNCT03086252Not applicable
- Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic AnemiaStatus unknownNCT03055078Phase 1
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- King's Invasive Aspergillosis Study IICompletedNCT02875743Phase 4
- Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic AnemiaStatus unknownNCT02857530Phase 2
- Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic AnemiaCompletedNCT02845596Not applicable
- ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic AnemiaStatus unknownNCT02838992Phase 4
- Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron OverloadStatus unknownNCT02833493
- Study of Romiplostim(AMG531) in Subjects With Aplastic AnemiaCompletedNCT02773290Phase 2/3
- Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)CompletedNCT02773225Phase 2/3
- The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic AnemiaCompletedNCT02745717Phase 4
- Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic SyndromeCompletedNCT02462252Phase 2
- Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic AnemiaStatus unknownNCT02407470Phase 1/2
- Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.Status unknownNCT02247973Phase 2
- Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell DiseaseCompletedNCT02225145
- A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic AnemiaCompletedNCT02203396Phase 2
- Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic EnterocolitisStatus unknownNCT02145923Phase 1/2
- hATG+CsA vs hATG+CsA+Eltrombopag for SAACompletedNCT02099747Phase 3
- Nandrolone Decanoate in the Treatment of TelomeropathiesCompletedNCT02055456Phase 1/2
- Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic AnaemiaStatus unknownNCT02028416Not applicable
- Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single VaccinationStatus unknownNCT02007811Phase 1/2
- Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic AnemiaStatus unknownNCT01997372Phase 4
- Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic AnemiaStatus unknownNCT01995331Phase 4
- CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell TransplantationActive, not recruitingNCT01966367Phase 1/2
- Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation TherapyCompletedNCT01956799
- Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.CompletedNCT01933035
- Safety Study of CD3/CD19 Depleted Haploidentical Stem CellsStatus unknownNCT01919866Phase 1/2
- Bone Marrow Transplant With Abatacept for Non-Malignant DiseasesCompletedNCT01917708Phase 1
- A Description of Bacteria in the Mouths of Patients With Severe Aplastic AnemiaCompletedNCT01900119
- Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe NeutropeniaStatus unknownNCT01849237Phase 1/2
- Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAAStatus unknownNCT01844635Phase 3
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)Status unknownNCT01760096Phase 2
- Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic AnemiaStatus unknownNCT01759732Phase 2
- Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood DisordersCompletedNCT01758042Not applicable
- Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic AnaemiaStatus unknownNCT01719341
- Collection of Blood and Bone Marrow From Patients With Aplastic Anemia for Analysis of Adhesion Molecules, Chemokines and Their ReceptorsWithdrawnNCT01680055
- Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis CongenitaActive, not recruitingNCT01659606Phase 2
- Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal HemoglobinuriaStatus unknownNCT01642979Phase 2
- Human Placental-Derived Stem Cell TransplantationCompletedNCT01586455Phase 1
- Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic AnemiaCompletedNCT01546415Phase 4
- Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic AnaemiaCompletedNCT01530555Phase 2
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTerminatedNCT01500161Phase 2
- Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell TransplantationStatus unknownNCT01472055Phase 2
- Alemtuzumab and Rituximab in Aplastic AnemiaWithdrawnNCT01408342Not applicable
- Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic AnemiaTerminatedNCT01383434Phase 2
- Unrelated Donor Stem Cell TransplantationCompletedNCT01364363Not applicable
- Cord Blood Transplantation in Severe Aplastic AnemiaCompletedNCT01343953Phase 2
- Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology PatientsTerminatedNCT01343680Phase 3
- Establishing a Data Base for Aplastic Anemia and Other Marrow Failure SyndromeStatus unknownNCT01310959
- Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.Status unknownNCT01305694Phase 1/2
- Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic AnemiaCompletedNCT01297972Phase 1/2
- Nonmyeloablative Allogeneic TransplantCompletedNCT01272817Not applicable
- Alefacept in Patients With Relapsed/Refractory Aplastic AnemiaTerminatedNCT01267643Phase 1
- High-Tc Susceptometer to Monitor Transfusional Iron OverloadCompletedNCT01241357
- Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological DisordersCompletedNCT01224496Phase 1/2
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantActive, not recruitingNCT01199562
- Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure SyndromesCompletedNCT01192425
- Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic AnemiaStatus unknownNCT01182662Phase 2
- Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)TerminatedNCT01163942Phase 3